Cargando…

Randomised controlled trials for mpox in endemic countries

Detalles Bibliográficos
Autores principales:	Rojek, Amanda, Dunning, Jake, Haynes, Richard, Horby, Peter, Peto, Leon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2023
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9946462/ https://www.ncbi.nlm.nih.gov/pubmed/36690011 http://dx.doi.org/10.1016/S1473-3099(23)00045-2

Ejemplares similares

MOSAIC: A cohort study of human mpox virus disease
por: Pesonel, Elise, et al.
Publicado: (2023)

Renaming monkeypox to Mpox: correspondence
por: Gupta, Parul C., et al.
Publicado: (2023)

Mpox Vaccination in Non-Endemic Countries: Considerations for Public Health and Policy
por: Ferrara, Pietro
Publicado: (2023)

Persistent ocular mpox infection in an immunocompetent individual
por: Raccagni, Angelo Roberto, et al.
Publicado: (2023)

When was mpox a public health emergency?
por: Cann, Stephen A Hoption
Publicado: (2023)

Tocilizumab in COVID-19 therapy: who benefits, and how? – Authors' reply
por: Horby, Peter, et al.
Publicado: (2021)

The emergence of mpox in Pakistan: An urgent call for preparedness and response
por: Mughal, Sanila, et al.
Publicado: (2023)

Allocated but not treated: the silent 16% – Authors' reply
por: Horby, Peter, et al.
Publicado: (2022)

Online Health Information Seeking for Mpox in Endemic and Nonendemic Countries: Google Trends Study
por: Shepherd, Thomas, et al.
Publicado: (2023)

Mpox screening in high-risk populations finds no asymptomatic cases
por: Van Dijck, Christophe, et al.
Publicado: (2023)

Projected burden and duration of the 2022 Monkeypox outbreaks in non-endemic countries
por: Bisanzio, Donal, et al.
Publicado: (2022)

Regulatory and Operational Complexities of Conducting a Clinical Treatment Trial During an Ebola Virus Disease Epidemic
por: Rojek, Amanda M, et al.
Publicado: (2018)

Accessing first doses of mpox vaccine made available in Victoria, Australia
por: Chow, Eric P.F., et al.
Publicado: (2023)

Atypical clinical features of mpox (monkeypox): a diagnostic challenge - Reply()
por: Pinto-Pulido, Elena Lucía, et al.
Publicado: (2023)

Asymptomatic Mpox Virus Infection in Subjects Presenting for MVA-BN Vaccine
por: Matusali, Giulia, et al.
Publicado: (2023)

Monkeypox (MPOX)-Related Knowledge and Vaccination Hesitancy in Non-Endemic Countries: Concise Literature Review
por: Lounis, Mohamed, et al.
Publicado: (2023)

Monkeypox outbreak in non-endemic countries: An ongoing outbreak
por: Rohilla, Ranjana, et al.
Publicado: (2023)

Mpox virus infects and injures human kidney organoids, but responding to antiviral treatment
por: Li, Pengfei, et al.
Publicado: (2023)

Establishing COVID-19 trials at scale and pace: Experience from the RECOVERY trial
por: Peto, Leon, et al.
Publicado: (2022)

Mpox and the need for improved diagnostics – correspondence
por: Patel, Shailesh K., et al.
Publicado: (2023)

Human death due to H5N1 amid the COVID-19 pandemic and Mpox outbreak: A call for action
por: Sah, Ranjit, et al.
Publicado: (2023)

Clinical progression of asynchronous cutaneous lesions in a patient with locally acquired mpox infection
por: Tsai, Chi-Hsuan, et al.
Publicado: (2023)

The need for better diagnostics to support diagnosis and surveillance in monkeypox endemic countries
por: Khalil, Asma, et al.
Publicado: (2023)

Monkeypox: how will we know if the treatments work?
por: Rojek, Amanda, et al.
Publicado: (2022)

Mpox vaccination in global perspective: priorities and challenges
por: Rana, Jigyasa, et al.
Publicado: (2023)

The WHO has ended public health emergency of international concern for mpox: assessment of upside and downside of this decision
por: Sarker, Rapty, et al.
Publicado: (2023)

Can ChatGPT/GPT-4 assist surgeons in confronting patients with Mpox and handling future epidemics?
por: He, Yongbin, et al.
Publicado: (2023)

Performance of different clinical trial designs to evaluate treatments during an epidemic
por: Brueckner, Matthias, et al.
Publicado: (2018)

Early triple antiviral therapy for COVID-19
por: Lee, Nelson, et al.
Publicado: (2020)

Clinical REsearch During Outbreaks (CREDO) Training for Low- and Middle-Income Countries
por: Kayem, Nzelle Delphine, et al.
Publicado: (2019)

Modernising epidemic science: enabling patient-centred research during epidemics
por: Rojek, Amanda M., et al.
Publicado: (2016)

Offering patients more: how the West Africa Ebola outbreak can shape innovation in therapeutic research for emerging and epidemic infections
por: Rojek, Amanda M., et al.
Publicado: (2017)

WHO declares end of mpox global health emergency: first glance from a perspective of ChatGPT/GPT-4
por: Lu, Yanqiu, et al.
Publicado: (2023)

Core Minimal Datasets to Advance Clinical Research for Priority Epidemic Diseases
por: Rojek, Amanda M, et al.
Publicado: (2020)

COVID-19 drug research and the cohort multiple randomised controlled trial design
por: Dal-Ré, Rafael
Publicado: (2022)

Mpox Infection in a Developed Country: A Case Report
por: Patalon, Tal, et al.
Publicado: (2022)

Mitigation Measures to Control the Expected Mpox Outbreak in a Developing Country—Pakistani Scenario
por: Malik, Shiza, et al.
Publicado: (2023)

How endemic is cholera in India?
por: Sarkar, B.L., et al.
Publicado: (2012)

Endemic Fluorosis in Western Kweichow
por: Lyth, Oliver
Publicado: (1945)

Does a "Level I Evidence" rating imply high quality of reporting in orthopaedic randomised controlled trials?
por: Poolman, Rudolf W, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_afu8url1fn2i8sgkrd7son3d9a